Affinivax Inc. Alternatives & Competitors

12 companies similar to Affinivax Inc.

Vaxinano

Developing life-changing vaccines and immunotherapies

13 Non Equity Assistance

Biotechnology Pharmaceutical +1

Prometheus Biosciences, Inc.

Revolutionizing medicine with precision.

31 Post-IPO Equity $951.84M

San Diego, United States

Biotechnology Health Care +2

7 Hills Pharma

First-in-concept platform of oral drugs to overcome immunotherapy resistance

12 Grant $23.20M

Houston, United States

Health Care Pharmaceutical

OXFORD VACMEDIX UK LIMITED

Developing therapeutic cancer vaccines using ROP technology

8 Series A $12.50M

Oxford, United Kingdom

Health Care Health and Wellness +1

Track all Affinivax Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Rocketvax AG

Implementing cutting-edge science in next-generation vaccine design that will improve peop...

6 Grant $5.20M

Basel, Switzerland

Biotechnology Health Care +2

Memgen, Inc.

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

7 Venture round

Houston, United States

Biotechnology Health Care +2

EMERGEX VACCINES LTD

A UK biotechnology company developing T cell-priming immune set-point candidates against i...

1 Grant $12.47M

United Kingdom

Biopharma Biotechnology +1

3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for br...

26 Series A $52.00M

South San Francisco, Unit...

Biopharma Biotechnology +1

HDT Bio

Immune Therapy For All

54 Seed $17.20M

Seattle, United States

Biopharma Biotechnology +1

Soligenix, Inc.

We are a late-stage biopharmaceutical company focused on developing & commercializing prod...

27 Post-IPO Equity $55.97M

Princeton, United States

Biopharma Biotechnology +1

Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...

171 Post-IPO Equity $400.00M

United States

Biotechnology Health Care +1

Compare

The Duke Human Vaccine Institute

Innovation, Collaboration and Excellence

214 Grant $43.40M

Durham, United States

Biotechnology Health Care

About Affinivax Inc.

Affinivax Inc. was acquired by GSK in August 2022. Founded in 2014, the United States-based company operates in the Biotechnology, Health Care, and Pharmaceutical industries.

Taxonomy

Affinivax, GSK, Vaccine Technologies, Preventive Vaccines, Therapeutic Vaccines, Infectious Diseases, Immune Mediated Diseases, Clinical Stage, Acquisition, Next Generation Approach, Research And Development, Pharmaceuticals, Innovation

Frequently Asked Questions

Companies similar to Affinivax Inc. include Vaxinano, Prometheus Biosciences, Inc., 7 Hills Pharma, OXFORD VACMEDIX UK LIMITED, Rocketvax AG. They work in Biotechnology and Health Care and share Affinivax Inc.'s focus on infectious diseases, therapeutic vaccines and pharmaceuticals.

Bounce Watch lists 12 companies that share Affinivax Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Affinivax Inc. was acquired by GSK in August 2022. Founded in 2014, the United States-based company operates in the Biotechnology, Health Care, and Pharmaceutical industries.

Don't just read about them. Follow them.

BounceWatch watches Affinivax Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Affinivax Inc. Profile Prometheus Biosciences, Inc. Alternatives OXFORD VACMEDIX UK LIMITED Alternatives Rocketvax AG Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Affinivax Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.